Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_assertion type Assertion NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_head.
- NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_assertion description "[In these hematopoietic cell lines, the vectors that contained ADA controlled by either the Moloney murine leukemia virus promoter (LASN) or the cytomegalovirus promoter (LNCA) expressed ADA at much higher levels than the other vectors tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_provenance.
- NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_assertion evidence source_evidence_literature NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_provenance.
- NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_assertion SIO_000772 2752148 NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_provenance.
- NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_assertion wasDerivedFrom befree-20140225 NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_provenance.
- NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_assertion wasGeneratedBy ECO_0000203 NP482825.RA2o3zx4qDOyyBhAarDW97dYbVRKvIMcCWPltLCp-nDgE130_provenance.